Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Pyxis Oncology Q2 EPS $(0.30) Beats $(0.35) Estimate, Sales $2.82M

Author: Benzinga Newsdesk | August 14, 2025 03:36pm
Pyxis Oncology (NASDAQ:PYXS) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.35) by 14.77 percent. This is a 3.45 percent decrease over losses of $(0.29) per share from the same period last year. The company reported $2.82 million in sales this quarter.

Posted In: PYXS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist